Zynex awarded noninvasive sepsis monitor patent in the UK

Zynex (ZYXI) announced it has been awarded UK patent 2617515 for a multiparameter, noninvasive sepsis monitor. Sepsis is a life-threatening condition characterized by systemic inflammation and organ dysfunction caused by an infection. Over half of sepsis cases are contracted in hospitals and have a high mortality rate due to the difficulty of early detection and diagnosis. According to the Centers for Disease Control, at least 1.7M people have sepsis each year in the U.S. alone, and in hospitals, 1 in 3 deaths is related to sepsis. On a global scale, sepsis kills 11 million people annually, accounting for roughly 20% of global deaths, and roughly half of sepsis cases are children under 5 years of age.